Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mesalazine 500mg/5ml oral liquid
0105010B0AAAVAV
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 4 |
|
Mesalazine 250mg suppositories
0105010B0AAAGAG
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 3 |
|
Mesren MR 400mg gastro-resistant tablets
0105010B0BGABAA
|
Mesren | Mesalazine (Systemic) | Gastro-Intestinal System | 1 |
|
Asacol 1g/application foam enema
0105010B0BBAEAK
|
Asacol | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
|
Asacol 250mg suppositories
0105010B0BBADAG
|
Asacol | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
|
Ipocol 400mg gastro-resistant tablets
0105010B0BFAAAA
|
Ipocol | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
|
Mesalazine 300mg/5ml oral suspension
0105010B0AABBBB
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
|
Mesalazine 400mg/5ml oral liquid
0105010B0AAAMAM
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
|
Zyduco XL 1200mg tablets
0105010B0BLAAAR
|
Zyduco | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.